Publicaciones (208) Publicaciones de ROCÍO GARCÍA CARBONERO

2023

  1. ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA

    Genome Medicine, Vol. 15, Núm. 1

  2. Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?

    Endocrine reviews, Vol. 44, Núm. 4, pp. 724-736

  3. Caracterización molecular de los tumores de páncreas y vías biliares

    Revista Methodo: Investigación Aplicada a las Ciencias Biológicas, Vol. 8, Núm. 2, pp. 71-85

  4. Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin

    Nature Communications, Vol. 14, Núm. 1

  5. European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours

    Journal of Neuroendocrinology, Vol. 35, Núm. 6

  6. Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study

    The Lancet, Vol. 402, Núm. 10395, pp. 41-53

  7. Health-related quality of life (HRQoL) associated with fruquintinib in the global phase 3, placebo-controlled, double-blind FRESCO-2 study.

    Journal of Clinical Oncology

  8. Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1–2 cm in size: a retrospective, Europe-wide, pooled cohort study

    The Lancet Oncology, Vol. 24, Núm. 2, pp. 187-194

  9. Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic Colorectal Cancer: PLATFORM-B Study

    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 29, Núm. 2, pp. 379-388

  10. MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms

    Molecular Oncology, Vol. 17, Núm. 4, pp. 582-597

  11. Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer

    Cancer Science, Vol. 114, Núm. 3, pp. 1026-1036

  12. SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022)

    Clinical and Translational Oncology, Vol. 25, Núm. 9, pp. 2692-2706

  13. Sex differences on multikinase inhibitors toxicity in patients with advanced gastroenteropancreatic neuroendocrine tumours

    European Journal of Cancer, Vol. 188, pp. 39-48

  14. Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402

    Journal of the National Cancer Institute, Vol. 115, Núm. 12, pp. 1497-1505